Michael Kanitz

1.7k total citations
24 papers, 1.3k citations indexed

About

Michael Kanitz is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Michael Kanitz has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Michael Kanitz's work include Thyroid Disorders and Treatments (18 papers), Ophthalmology and Eye Disorders (10 papers) and Ion channel regulation and function (3 papers). Michael Kanitz is often cited by papers focused on Thyroid Disorders and Treatments (18 papers), Ophthalmology and Eye Disorders (10 papers) and Ion channel regulation and function (3 papers). Michael Kanitz collaborates with scholars based in Germany, United States and Poland. Michael Kanitz's co-authors include George J. Kahaly, Tanja Diana, Paul D. Olivo, Katharina A. Ponto, J. König, Susanne Pitz, Christian Wüster, N. Matheis, Simon D. Lytton and Leonard D. Kohn and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Ophthalmology.

In The Last Decade

Michael Kanitz

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kanitz Germany 18 882 633 181 170 135 24 1.3k
Tamotsu Yokota Japan 21 315 0.4× 94 0.1× 589 3.3× 162 1.0× 83 0.6× 37 1.4k
Tina Soulis Australia 12 434 0.5× 168 0.3× 220 1.2× 180 1.1× 63 0.5× 14 1.2k
Mototaka Yoshinari Japan 21 486 0.6× 60 0.1× 235 1.3× 147 0.9× 52 0.4× 50 1.0k
Sherif Youssef Australia 8 231 0.3× 74 0.1× 265 1.5× 118 0.7× 66 0.5× 14 963
Yuko Jinnouchi Japan 14 233 0.3× 92 0.1× 287 1.6× 116 0.7× 234 1.7× 17 989
Delphine Mirebeau‐Prunier France 17 225 0.3× 130 0.2× 519 2.9× 129 0.8× 23 0.2× 58 976
A M Schmidt United States 8 263 0.3× 85 0.1× 231 1.3× 391 2.3× 25 0.2× 10 1.0k
Yuichi Hamada Japan 16 149 0.2× 56 0.1× 236 1.3× 220 1.3× 108 0.8× 38 803
Klaus Kusterer Germany 20 236 0.3× 78 0.1× 221 1.2× 231 1.4× 11 0.1× 51 1.1k
Yuri Nishino Japan 16 441 0.5× 56 0.1× 202 1.1× 83 0.5× 32 0.2× 28 912

Countries citing papers authored by Michael Kanitz

Since Specialization
Citations

This map shows the geographic impact of Michael Kanitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kanitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kanitz more than expected).

Fields of papers citing papers by Michael Kanitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kanitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kanitz. The network helps show where Michael Kanitz may publish in the future.

Co-authorship network of co-authors of Michael Kanitz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kanitz. A scholar is included among the top collaborators of Michael Kanitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kanitz. Michael Kanitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diana, Tanja, Martin Ungerer, Christian Wüster, et al.. (2021). A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves’ disease mouse model. Journal of Autoimmunity. 122. 102666–102666. 17 indexed citations
2.
Diana, Tanja, Hans‐Peter Holthoff, Christian Wüster, et al.. (2020). A Novel Long-Term Graves’ Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies. European Thyroid Journal. 9(Suppl. 1). 51–58. 21 indexed citations
3.
Kahaly, George J., Tanja Diana, Michael Kanitz, & Paul D. Olivo. (2020). OR18-03 Functional TSH Receptor Antibodies Are a Biomarker for Graves’ Disease - a Prospective Trial. Journal of the Endocrine Society. 4(Supplement_1). 1 indexed citations
4.
Kahaly, George J., Tanja Diana, Michael Kanitz, Lara Frommer, & Paul D. Olivo. (2019). Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease. The Journal of Clinical Endocrinology & Metabolism. 105(4). e1006–e1014. 64 indexed citations
5.
Diana, Tanja, Paul D. Olivo, Yie‐Hwa Chang, et al.. (2019). Comparison of a Novel Homogeneous Cyclic Amp Assay and a Luciferase Assay for Measuring Stimulating Thyrotropin-Receptor Autoantibodies. European Thyroid Journal. 9(2). 67–72. 12 indexed citations
6.
Diana, Tanja, Jesse S. Krause, Paul D. Olivo, et al.. (2017). Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease. Clinical & Experimental Immunology. 189(3). 304–309. 53 indexed citations
7.
Diana, Tanja, Christian Wüster, Paul D. Olivo, et al.. (2017). Performance and Specificity of 6 Immunoassays for TSH Receptor Antibodies: A Multicenter Study. European Thyroid Journal. 6(5). 243–249. 57 indexed citations
8.
Kahaly, George J., et al.. (2016). Thyroid Stimulating Antibodies Are Highly Prevalent in Hashimoto's Thyroiditis and Associated Orbitopathy. The Journal of Clinical Endocrinology & Metabolism. 101(5). 1998–2004. 81 indexed citations
9.
Diana, Tanja, Yunsheng Li, Paul D. Olivo, et al.. (2016). Analytical Performance and Validation of a Bioassay for Thyroid-Blocking Antibodies. Thyroid. 26(5). 734–740. 34 indexed citations
10.
Diana, Tanja, Christian Wüster, Michael Kanitz, & George J. Kahaly. (2016). Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies. Journal of Endocrinological Investigation. 39(10). 1159–1165. 61 indexed citations
11.
Diana, Tanja, et al.. (2015). Thyroid Stimulating but Not Blocking Autoantibodies Are Highly Prevalent in Severe and Active Thyroid-Associated Orbitopathy: A Prospective Study. International Journal of Endocrinology. 2015. 1–5. 54 indexed citations
12.
Diana, Tanja, et al.. (2014). Standardization of a Bioassay for Thyrotropin Receptor Stimulating Autoantibodies. Thyroid. 25(2). 169–175. 52 indexed citations
13.
Diana, Tanja, Rosalind S. Brown, Artur Bossowski, et al.. (2014). Clinical Relevance of Thyroid-Stimulating Autoantibodies in Pediatric Graves' Disease—A Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. 99(5). 1648–1655. 84 indexed citations
14.
Ponto, Katharina A., Michael Kanitz, Paul D. Olivo, et al.. (2011). Clinical Relevance of Thyroid-Stimulating Immunoglobulins in Graves' Ophthalmopathy. Ophthalmology. 118(11). 2279–2285. 101 indexed citations
15.
Lytton, Simon D., Katharina A. Ponto, Michael Kanitz, et al.. (2010). A Novel Thyroid Stimulating Immunoglobulin Bioassay Is a Functional Indicator of Activity and Severity of Graves’ Orbitopathy. The Journal of Clinical Endocrinology & Metabolism. 95(5). 2123–2131. 164 indexed citations
16.
Dittmar, Manuela, et al.. (2007). Impaired Deoxyribonuclease Activity in Monoglandular and Polyglandular Autoimmunity. Experimental and Clinical Endocrinology & Diabetes. 115(6). 387–391. 10 indexed citations
17.
Dittmar, Manuela, et al.. (2007). Polymorphismen des MICA-Mikrosatelliten bei thyreoidaler Autoimmunität. Medizinische Klinik. 102(1). 11–15. 10 indexed citations
18.
Schiekofer, Stephan, Gottfried Rudofsky, M. Andrassy, et al.. (2003). Glimepiride reduces mononuclear activation of the redox‐sensitive transcription factor nuclear factor‐kappa B. Diabetes Obesity and Metabolism. 5(4). 251–261. 11 indexed citations
19.
Hofmann, M., Stephan Schiekofer, Berend Isermann, et al.. (1999). Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB. Diabetologia. 42(2). 222–232. 154 indexed citations
20.
Kanitz, Michael, et al.. (1994). In vivo expression of P-glycoprotein in a human colon carcinoma xenograft is modulated by therapy with free and monoclonal antibody-conjugated vinca alkaloids.. PubMed. 14(3A). 857–68. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamotsu Yokota Breakdown of academic impact, for papers by Tina Soulis Breakdown of academic impact, for papers by Mototaka Yoshinari Breakdown of academic impact, for papers by Sherif Youssef Breakdown of academic impact, for papers by Yuko Jinnouchi Breakdown of academic impact, for papers by Delphine Mirebeau‐Prunier Breakdown of academic impact, for papers by A M Schmidt Breakdown of academic impact, for papers by Yuichi Hamada Breakdown of academic impact, for papers by Klaus Kusterer Breakdown of academic impact, for papers by Yuri Nishino
Rankless by CCL
2026